Vés al contingut

Judith Balmaña Gelpí

Institucions de les que formen part

Investigador/a principal
Vall Hebron Institut de Recerca

Judith Balmaña Gelpí

Institucions de les que formen part

Investigador/a principal
Vall Hebron Institut de Recerca

Línies de recerca

Impact of genetic testing in hereditary cancer syndromes (Projecte IMASS). In collaboration with three other units, this project is led by Vall d’Hebron University Hospital.

IP: Judith Balmaña Gelpí

Efficacy and comparison of two different molecular strategies for screening of individuals at risk of Lynch syndrome.

IP: Judith Balmaña Gelpí

Identification of mutations in the ATM gene in families with hereditary breast families and no mutation identified in the BRCA genes. We are co-investigators of this project with Orland Díez and Sara Gutiérrez, from the genetic laboratory.

IP: Judith Balmaña Gelpí

Extension and validation of the PREMM1,2 model and validation of other predictive models for Lynch syndrome. We are collaborating with Dr Sapna Syngal, from the Dana-Farber Cancer Institute and Ewout Steyerberg, from the Erasmus Medical Center, in this ongoing project. An NIH grant has been obtained to fund this project.

IP: Judith Balmaña Gelpí

Subscriu-te als nostres butlletins i forma part de la vida del Campus

El Vall d’Hebron Barcelona Hospital Campus és un parc sanitari de referència mundial on assistència, recerca, docència i innovació es donen la mà.